Clarivate analytics US LLC r & d for developing mcms for chemical threats using drug repositioning (AOI #5 redirect)
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50121C00031
- Awardee
-
Clarivate Analytics (Us) LLC UEI KCEFDML72122
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $749,201
Award facts
- Opportunity
-
- BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement Solicitation · BAA20100SOL0002 · Posted Feb 3, 2020
- Contract value 100% obligated
- $749,201.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Alexandria, VA 22314, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $749,201 |
About this award
Clarivate Analytics (US) LLC received a $749,201 firm fixed-price contract award from the Office of the Assistant Secretary for Preparedness and Response (ASPR) on September 20, 2021, for research and development focused on developing medical countermeasures (MCMs) for chemical threats using drug repositioning methodologies. The work was performed in Alexandria, Virginia, with an ultimate completion date of February 28, 2023. This contract was issued under Executive Order 14042 and represents a redirect to Area of Interest #5, with no set-aside designation applied to the award.
Clarivate Analytics, a global provider of scientific, technical, medical, and scholarly research databases and analytics platforms, brought its specialized expertise in research intelligence and drug discovery tools to support ASPR's preparedness mission. The company's involvement in developing MCMs through drug repositioning aligns with its core competency in providing advanced research analytics and proprietary databases that facilitate scientific discovery. ASPR's mission to enhance the nation's ability to prepare for and respond to public health emergencies makes this research and development effort critical to identifying existing therapeutic agents that could be repurposed to counter chemical threats, thereby strengthening the federal government's medical countermeasure stockpile and response capabilities.
Quick answers
Who was awarded contract 75A50121C00031?
75A50121C00031 was awarded to Clarivate Analytics (Us) LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 20, 2021.
How much is contract 75A50121C00031 worth?
The government has obligated $749,201 on 75A50121C00031.
Was contract 75A50121C00031 competed?
The extent of competition for 75A50121C00031 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award